ARTHROPLASTY
Autologous platelet gel does not have a clinically relevant effect in TKA
Knee Surg Sports Traumatol Arthrosc. 2011 Jan;19(1):115-21. doi: 10.1007/s00167-010-1207-0. Epub 2010 Jul 1840 patients scheduled to undergo total knee arthroplasty (TKA) were randomized to receive adjunctive treatment with autologous platelet gel (APG) or no adjunctive treatment (control) to investigate haemostatic, healing and functional benefits. Throughout the hospital stay, APG use resulted in smaller haematomas, less pain on 3rd day, no wound healing complications, and shorter hospital stay. The findings, however, were marginal and not clinically significant.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
